Quick Answer
AbCellera Biologics Inc. reported Research And Development Expense of $186.83 million for the year ending 2025.
- AbCellera Biologics Inc. showed an increase of +11.7% in Research And Development Expense from 2024 to 2025.
- This data is from AbCellera Biologics Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), AbCellera Biologics Inc.'s Research And Development Expense has grown by 1,747.4%.
- Historical annual values: Fiscal year 2025: $186.83 million | Fiscal year 2024: $167.26 million | Fiscal year 2023: $175.66 million | Fiscal year 2022: $107.88 million | Fiscal year 2021: $62.06 million | Fiscal year 2020: $29.39 million | Fiscal year 2019: $10.11 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: